Thursday, July 27, 2017

Cyrus Biotechnology Raises $8M In Series A

Seattle-based Cyrus Biotechnology, a biotechnology software developer focused on protein modeling and design, has raised $8M in a Series A funding, the company said this morning. The funding was led by Trinity Ventures, and also included OrbiMed Advisors, SpringRock Ventures, W Fund and individuals. Cyrus is led by Dr. Lucas Nivon, its CEO. More information »